128 related articles for article (PubMed ID: 31423250)
1. Effect of prophylactic TACE on 5-year survival of patients with hepatocellular carcinoma after hepatectomy.
He S; Fan X; Ma H; Xiaerfuhazi H; Rehato A; Feng J; Shi X; He F
Oncol Lett; 2019 Aug; 18(2):1824-1830. PubMed ID: 31423250
[TBL] [Abstract][Full Text] [Related]
2. Survival prediction model for postoperative hepatocellular carcinoma patients.
Ren Z; He S; Fan X; He F; Sang W; Bao Y; Ren W; Zhao J; Ji X; Wen H
Medicine (Baltimore); 2017 Sep; 96(37):e7902. PubMed ID: 28906371
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
5. [Effect of sorafenib and prophylactic TACE for prevention of postoperative relapse in patients with liver cancer combined with microvascular invasion].
Shen PC; Gao ZQ; Li DY; Tang Z
Zhonghua Gan Zang Bing Za Zhi; 2020 May; 28(5):416-420. PubMed ID: 32536058
[No Abstract] [Full Text] [Related]
6. Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma.
Li Z; Lei Z; Xia Y; Li J; Wang K; Zhang H; Wan X; Yang T; Zhou W; Wu M; Pawlik TM; Lau WY; Shen F
JAMA Surg; 2018 Oct; 153(10):e182721. PubMed ID: 30073257
[TBL] [Abstract][Full Text] [Related]
7. Serum STIP1, a Novel Indicator for Microvascular Invasion, Predicts Outcomes and Treatment Response in Hepatocellular Carcinoma.
Ma XL; Tang WG; Yang MJ; Xie SH; Wu ML; Lin G; Lu RQ
Front Oncol; 2020; 10():511. PubMed ID: 32426271
[No Abstract] [Full Text] [Related]
8. Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety.
Wei W; Jian PE; Li SH; Guo ZX; Zhang YF; Ling YH; Lin XJ; Xu L; Shi M; Zheng L; Chen MS; Guo RP
Cancer Commun (Lond); 2018 Oct; 38(1):61. PubMed ID: 30305149
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant trans-arterial chemoembolization after hepatectomy significantly improves the prognosis of low-risk patients with R0-stage hepatocellular carcinoma.
Xie H; Tian S; Cui L; Yan J; Bai Y; Li X; Wang M; Zhang F; Duan F
Cancer Manag Res; 2019; 11():4065-4073. PubMed ID: 31118814
[No Abstract] [Full Text] [Related]
10. Preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: a single center analysis.
Jianyong L; Jinjing Z; Wentao W; Lunan Y; Qiao Z; Bo L; Tianfu W; Minqing X; Jiaying Y; Yongang W
Ann Hepatol; 2014; 13(4):394-402. PubMed ID: 24927610
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
[No Abstract] [Full Text] [Related]
12. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
[TBL] [Abstract][Full Text] [Related]
13. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
Zhang DZ; Wei XD; Wang XP
World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
[TBL] [Abstract][Full Text] [Related]
15. Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study.
Ren ZG; Lin ZY; Xia JL; Ye SL; Ma ZC; Ye QH; Qin LX; Wu ZQ; Fan J; Tang ZY
World J Gastroenterol; 2004 Oct; 10(19):2791-4. PubMed ID: 15334671
[TBL] [Abstract][Full Text] [Related]
16. Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion.
Lee D; Lee HC; An J; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS
Clin Mol Hepatol; 2018 Jun; 24(2):144-150. PubMed ID: 29665630
[TBL] [Abstract][Full Text] [Related]
17. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
Peng Z; Chen S; Xiao H; Wang Y; Li J; Mei J; Chen Z; Zhou Q; Feng S; Chen M; Qian G; Peng S; Kuang M
Radiology; 2019 Jul; 292(1):237-247. PubMed ID: 31135299
[TBL] [Abstract][Full Text] [Related]
18. Parametric response mapping cut-off values that predict survival of hepatocellular carcinoma patients after TACE.
Nörthen A; Asendorf T; Shin HO; Hinrichs JB; Werncke T; Vogel A; Kirstein MM; Wacker FK; Rodt T
Abdom Radiol (NY); 2018 Dec; 43(12):3288-3300. PubMed ID: 29680967
[TBL] [Abstract][Full Text] [Related]
19. Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion.
Sun JJ; Wang K; Zhang CZ; Guo WX; Shi J; Cong WM; Wu MC; Lau WY; Cheng SQ
Ann Surg Oncol; 2016 Apr; 23(4):1344-51. PubMed ID: 26714945
[TBL] [Abstract][Full Text] [Related]
20. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
